Radiation Therapy Quality Assurance (QA) Phantoms Market Top Players - Computerized Imaging Reference Systems, Inc., Fluke Biomedical, IBA Dosimetry, Modus Medical Devices Inc.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radiation Therapy Quality Assurance (QA) Phantoms Market By Technology (Linear Accelerators, Cobalt-60, High-Dose Radiation, And Low-Dose Radiation), Therapy (External Radiation Therapy (Photon Beam Radiation Therapy, Advanced Three-Dimensional Conformal Radiation Therapy (3-D CRT), Volumetric Modulated Arc Therapy (VMAT), Image Guided Radiation Therapy (IGRT), Stereotactic Radiation Therapy, Intraoperative Radiotherapy (IORT), Proton Beam Therapy & Neutron Beam Therapy) and Internal Radiation Therapy Or Brachytherap) - Trends, Industry Competition Analysis, Revenue and Forecast To 2034."

The radiation therapy quality assurance (QA) phantoms global market is estimated to reach over USD 57.8 Mn by the year 2034, exhibiting a CAGR of 6.7% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1384

Radiation oncology is a specialized branch of medicine focused on the use of radiation for cancer treatment. Quality assurance (QA) protocols play a vital role in this domain, involving systematic and scheduled testing of medical equipment using phantoms on a daily, monthly, and annual basis. These QA procedures encompass critical elements such as beam calibration, dose verification, treatment planning system accuracy, and patient positioning validation.

The market for radiation oncology QA solutions is witnessing significant growth, largely driven by the increasing incidence of lifestyle-related conditions-including heart failure, chronic kidney disease, and chronic obstructive pulmonary disease (COPD)-which necessitate advanced diagnostic imaging and precision treatment. Growing awareness of the importance of structured QA programs in radiation therapy is further supporting market expansion, as these programs help medical physicists enhance patient safety and therapeutic outcomes.

Technological advancements, particularly in image-guided radiation therapy (IGRT) and intensity-modulated radiation therapy (IMRT), are gaining traction, especially in emerging markets seeking to modernize cancer care infrastructure. Moreover, leading medical device manufacturers are increasingly focusing on developing innovative error-reduction methodologies, such as failure mode and effects analysis (FMEA), to mitigate dose-related errors and improve the overall efficacy and reliability of radiation-based treatments.

List of Prominent Players in the Radiation Therapy Quality Assurance (QA) Phantoms Market:
Computerized Imaging Reference Systems, Inc.
Fluke Biomedical
IBA Dosimetry
Modus Medical Devices Inc.
PTW Freiburg GmbH
Standard Imaging Inc.
Sun Nuclear Corporation
The Phantom Laboratory, Inc.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Market Dynamics
Drivers:
The global increase in cancer prevalence is a key driver fueling the demand for radiation therapy quality assurance (QA) phantoms. As one of the most effective modalities for cancer treatment, radiation therapy is anticipated to significantly contribute to market growth over the forecast period. Moreover, the widespread adoption of advanced imaging technologies across the healthcare sector is further supporting this expansion. The rising burden of chronic conditions such as cancer, tuberculosis, and HIV underscores the need for accurate diagnostic and therapeutic imaging solutions. Given that medical imaging is central to both diagnosis and treatment planning, the demand for precision imaging tools continues to rise.

Challenges:
Despite its clinical importance, the delivery of high-quality radiation therapy demands a highly trained, dedicated workforce. A shortage of qualified professionals and technical expertise remains a major constraint, impeding the broader adoption of modern radiation technologies. As a result, access to advanced radiotherapy remains limited for many cancer patients. Additionally, the market faces challenges such as insufficient awareness among end users regarding safety and quality assurance protocols, as well as complex regulatory compliance requirements, which may hinder global market progression.

Regional Trends:
North America is expected to maintain a dominant position in the global market throughout the forecast period, supported by high healthcare spending and extensive deployment of advanced imaging systems, including computed tomography (CT) and magnetic resonance imaging (MRI) scanners. Increased awareness and utilization of diagnostic imaging in the United States and Canada, along with robust R&D activities and the availability of cutting-edge cancer treatment technologies, are projected to reinforce regional market growth. Strategic partnerships among key industry players are also contributing to market expansion.

In contrast, the Asia-Pacific region is poised for substantial growth, driven by a rising incidence of lifestyle-related diseases-such as cardiac failure, which affects an estimated 4.2 million individuals in China alone. The need for timely and accurate diagnosis is propelling demand for radiation therapy QA phantoms. Additional growth factors include an expanding base of trained healthcare professionals, heightened demand for advanced diagnostic technologies, and the increasing appeal of medical tourism in emerging markets. These elements collectively contribute to the robust market outlook in the Asia-Pacific region.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1384

Recent Developments:
• In November 2020, QRM GmbH and PTW Freiburg GmbH (PTW) signed a distribution agreement. From January 1, 2021, PTW will be the sole global distributor of QRM's tissue-equivalent phantoms. Following PTW's acquisition of a controlling stake in QRM GmbH earlier this year and tight collaboration in the development of PTW's new modular phantom platform Ruby, the two businesses have now moved their relationship to the next level.
• In October 2020, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital and PTW Freiburg GmbH signed an agreement to collaborate on developing an advanced EPID-based dosimetry solution for automated patient-specific quality assurance during radiotherapy treatment.

Segmentation of Radiation Therapy Quality Assurance (QA) Phantoms Market-
By Technology
• Linear Accelerators
• Cobalt-60
• High-Dose Radiation
• Low-Dose Radiation
By Therapy
• External Radiation Therapy
o Photon Beam Radiation Therapy
o Advanced three-Dimensional Conformal Radiation Therapy (3-D CRT)
o Volumetric Modulated Arc Therapy (VMAT)
o Image Guided Radiation Therapy (IGRT)
o Stereotactic Radiation Therapy
o Intraoperative Radiotherapy (IORT)
o Proton Beam Therapy
o Neutron Beam Therapy
• Internal Radiation Therapy or Brachytherapy
By Region-
• North America-
o US
o Canada
o Mexico
• Europe-
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• Asia-Pacific-
o China
o Japan
o India
o South Korea
o South East Asia
o Rest of Asia Pacific
• Latin America-
o Brazil
o Argentina
o Rest of Latin America
• Middle East & Africa-
o GCC Countries
o South Africa
o Rest of the Middle East and Africa
• Others

Read Overview Report- https://www.insightaceanalytic.com/report/global-radiation-therapy-quality-assurance-phantoms-market/1384

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.